CT-Based Radiomics for Predicting PD-L1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.
Journal:
Academic radiology
Published Date:
May 29, 2025
Abstract
BACKGROUND AND PURPOSE: The efficacy of immunotherapy in non-small cell lung cancer (NSCLC) is intricately associated with baseline PD-L1 expression rates. The standard method for measuring PD-L1 is immunohistochemistry, which is invasive and may not capture tumor heterogeneity. The primary aim of the current study is to assess whether CT-based radiomics models can accurately predict PD-L1 expression status in NSCLC and evaluate their quality and potential gaps in their design.
Authors
Keywords
No keywords available for this article.